WellPoint's earnings drop, but investors pleased; FDA recommends genetic testing before AIDS drugs;

> Though WellPoint Inc.'s earnings dropped 10 percent in the second quarter, investors seem pleased that the company is improving on previous mistakes of inaccurate medical cost assessments and missing earnings projections. Article

> According to a study in the New England Journal of Medicine, researchers in the U.K. found a genetic variant that causes myopathy--a muscle weakness--in patients taking cholesterol-lowering statins. Article

> The FDA is recommending genetic testing before doctors prescribe an AIDS medication called Abacavir--sold as Ziagen--as part of the personalized medicine movement, which seeks to find a suitable drug match for individual patients. Researchers say the screening would help cut down on negative reactions. Article

> Bill Gates and New York City Mayor Michael Bloomberg have teamed up to donate $500 million to prevent smoking and deaths related to smoking around the world. Article

And Finally... Talula Does The Hula From Hawaii--a first name? Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.